LY3857210

DRUG4 trials

Sponsors

Eli Lilly and Company

Conditions

Chronic Low-back PainDiabetic Peripheral Neuropathic PainHealthyOsteoarthritis

Phase 1

A Study of LY3857210 in Healthy Participants

CompletedNCT05292040

Eli Lilly and CompanyHealthy

Start: 2022-03-17End: 2022-12-14Updated: 2023-03-01

Phase 2

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain

CompletedNCT05620563

Eli Lilly and CompanyOsteoarthritis

Start: 2022-11-22End: 2023-06-12Updated: 2024-06-26

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).

CompletedNCT05620576

Eli Lilly and CompanyDiabetic Peripheral Neuropathic Pain

Start: 2022-11-14End: 2023-08-01Updated: 2024-08-07

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain

CompletedNCT05630196

Eli Lilly and CompanyChronic Low-back Pain

Start: 2022-12-08End: 2023-06-15Updated: 2024-08-13